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Abstract
Brain development and deterioration across the lifespan are integral to the etiology of late-life neurodegenerative disease. 
Factors that influence the health of the adult brain remain to be elucidated and include risk factors, protective factors, and 
factors related to cognitive and brain reserve. To address this knowledge gap we designed a life-course study on brain health, 
which received funding through the EU ERC Programme under the name Origins of Alzheimer’s Disease Across the Life 
course (ORACLE) Study. The ORACLE Study is embedded within Generation R, a prospective population-based cohort 
study of children and their parents, and links this with the Rotterdam Study, a population-based study in middle-aged and 
elderly persons. The studies are based in Rotterdam, the Netherlands. Generation R focuses on child health from fetal life 
until adolescence with repeated in-person examinations, but has also included data collection on the children’s parents. The 
ORACLE Study aims to extend the parental data collection in nearly 2000 parents with extensive measures on brain health, 
including neuroimaging, cognitive testing and motor testing. Additionally, questionnaires on migraine, depressive symptoms, 
sleep, and neurological family history were completed. These data allow for the investigation of longitudinal influences on 
adult brain health as well as intergenerational designs involving children and parents. As a secondary focus, the sampling is 
enriched by mothers (n = 356) that suffered from hypertensive disorders during pregnancy in order to study brain health in 
this high-risk population. This article provides an overview of the rationale and the design of the ORACLE Study.
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Introduction
The number of Alzheimer’s disease (AD) cases is projected 
to double or even triple by 2050 [1, 2], which emphasizes 
the urgency to disentangle the etiology of AD and to develop 
effective preventative strategies. Although AD has an onset 
late in life, the risk to develop AD is influenced by both 
early-life and adulthood factors [3–5], including cognitive 
and academic performance [6–9], cardiovascular health 
[10–12], lifestyle factors [13–20] and life events [21–24]. 
These factors likely affect the susceptibility to develop AD 
through mechanisms such as cognitive and brain reserve [25, 
26]. These mechanisms have been hypothesized to reduce or 
buffer the effect of brain pathology and aging.
The influence that the risk factors have on the incidence 
of AD likely depends on the life phase [27]. For example, 
hypertension during midlife has more influence on the risk of 
AD than hypertension later in life [28]. However, it is unclear 
whether hypertension during earlier phases of life also affect 
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the incidence of dementia, and to what extent. Similarly, most 
studies on risk factors and compensatory mechanisms have 
primarily focused on midlife and beyond. It remains to be elu-
cidated whether the risk factors already exert their effect on the 
etiology of AD during earlier phases of adulthood, and through 
which mechanisms.
Through the EU ERC Programme, funding was secured 
for a program entitled The Origins of Alzheimer’s Disease 
Across the Life course (ORACLE) Study, which aims to fur-
ther elucidate the age at which AD risk factors start affecting 
brain health and to further understand the underlying mecha-
nisms. The ORACLE Study is embedded within the Genera-
tion R Study [29], a prospective birth cohort established in 
2002 that focuses on health development from fetal life until 
early adulthood. The parents of the children had a mean age 
of 30.9 years (standard deviation: 5.7) at study intake and par-
ticipated in extensive measures of their health. The ORACLE 
Study started in 2017, as a dedicated research visit for the par-
ents to conduct extensive measures on brain health, including 
neuroimaging and cognitive testing.
The ORACLE Study has several aims. The first aim is to 
elucidate the associations of established and promising AD 
risk factors that were collected during previous Generation 
R visits with cognitive and brain measures from the ORA-
CLE research visit. Such factors will include vascular risk 
factors like blood pressure and lipid profiles, mental health 
metrics such as depressive-like symptoms, and lifestyle fac-
tors like daily exercise. A second aim is to consider how brain 
health develops over a lifetime. The ORACLE Study bridges 
the age gap between the children of the Generation R Study 
and participants from the Rotterdam Study [30], a prospec-
tive cohort study in individuals aged 45 years and older. By 
combining these three study populations, brain health can be 
studied across the life course. Furthermore, intergenerational 
effects can be examined by combining neuroimaging data from 
children and parents of the Generation R Study. A third aim 
is to study hypertensive disorders of pregnancy (HDP) and 
their impact on subsequent brain health and cognitive per-
formance, as Generation R has extensive prenatal data. HDP 
affect 2–10% of all pregnancies and have been implicated as a 
potential risk factor for dementia [31]. However, little is known 
on how it influences subsequent brain health. The ORACLE 
Study will provide a unique opportunity to investigate the role 
of AD risk factors and HDP in brain health across adulthood.
In this manuscript, we give an overview of the measures 




The ORACLE Study is embedded in the Generation R 
Study, a population-based prospective cohort study from 
fetal life onwards based in Rotterdam, the Netherlands 
[29, 32]. The Generation R Study was designed to iden-
tify early environmental and genetic causes of normal 
and abnormal growth, development and health from fetal 
life until young adulthood [29]. All pregnant women liv-
ing in Rotterdam with an expected delivery date between 
April 2002 and January 2006 were invited to participate. 
A total of 9778 pregnant mothers and 6347 partners were 
recruited into the Generation R cohort, which led to 9749 
live born children. A subset of 1232 children and their 
parents—the “Focus subcohort”—have partaken in addi-
tional detailed measurements of both fetal and postnatal 
growth and development. A schematic overview of the 
Generation R Study is shown in Fig. 1. All measures that 
have been performed in the parents of the Generation R 
Study have been described elsewhere [29, 32]. The Gener-
ation R Study and the ORACLE Study have been approved 
by Medical Ethical Committee of the Erasmus Medical 
Center Rotterdam, the Netherlands. All participants have 
to provide written informed consent before participating 
in the study.
The ORACLE Study
The ORACLE Study is designed to test how factors dur-
ing early adulthood affect brain health and structure at later 
ages. The parents within the Generation R Study provide a 
unique opportunity to tackle such questions. The parents had 
a mean age of 30.9 years (standard deviation: 5.7) at study 
baseline and data were collected for multiple factors that 
play a role in later adulthood brain health and the etiology of 
AD, like cardiovascular functioning, lifestyle and life events. 
To explore whether and how these factors measured during 
early adulthood affect consequent brain health in middle 
adulthood, we introduced the ORACLE Study. It consists 
of a parental research visit, with the goal to conduct cogni-
tive testing, extensive neuroimaging and an assortment of 
other physiological and functional measures.
The ORACLE Study started in May 2017 and is still 
ongoing. The aim is to recruit 2,000 parents whose children 
had also participated in the most recent wave of the Genera-
tion R Study (2016–2019). We have invited all parents from 
the Focus subcohort. The sample is further supplemented 
by randomly selecting parents from the whole Generation R 
cohort until 2,000 individuals have participated.
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The ORACLE Study aims to form a bridge between 
two population-based cohorts: The Generation R Study 
[29] and the Rotterdam Study [30]. The Generation R 
Study focuses on early life (childhood, adolescence), the 
ORACLE Study includes individuals during early and mid 
adulthood, and the Rotterdam Study covers mid adulthood 
until the end of life. By combining these three studies, 
brain health can roughly be studied from a life-course per-
spective. To harmonize the studies, the ORACLE Study 
has adapted the cognitive test battery from the Rotterdam 
Study as well as a similar set of brain magnetic resonance 
imaging (MRI) sequences.
Hypertensive disorders of pregnancy
A secondary aim is to assess whether HDP affects the struc-
ture and function of the post-pregnancy brain. As such, we 
aim to invite all mothers who had experienced HDP during 
their index pregnancy. HDP was determined for every preg-
nancy during the initial phase of the Generation R Study. 
Obstetric records were obtained from the midwife and hos-
pital registries [29, 33]. HDP was defined as pre-eclampsia 
and gestational hypertension. We used the criteria according 
to the International Society for the Study of Hypertension 
in Pregnancy of 2001 [34]. Therefore, gestational hyperten-
sion was defined as development of a systolic blood pres-
sure ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg 
without proteinuria after 20 weeks of gestation in previ-
ous normotensive women. Preeclampsia was defined as a 
new onset of hypertension with a SBP ≥ 140 mmHg or a 
DBP ≥ 90 mmHg and proteinuria (≥ 300 mg/day) at or after 
20 weeks of gestational age. A total of 356 women with 
HDP were eligible for inclusion, and they were invited irre-
spective of being part of the Focus subcohort.
Measures
An overview of the ORACLE research visit and all meas-
ures is given in Fig. 2. The visit starts with a cognitive test 
battery consisting of six tests (see “Cognitive testing” sec-
tion): (1)the 15-word learning test, (2) the Stroop task, (3) a 
letter-digit substitution test, (4) a verbal fluency test, (5) the 
Purdue pegboard test and (6) the design organization test. 
The cognitive battery is followed by an assessment of gait 
(“Gait assessment” section), a blood pressure measurement 
(“Blood pressure and anthropometry” section) and ques-
tionnaires (“Questionnaires” section). The participants are 
then scanned in an MRI scanner, and the session lasts for 
30 min (“Neuroimaging” section). The total visit duration 
is approximately 65 to 80 min.
Neuroimaging
The aims of the neuroimaging are to:
• map and quantify the structure of the gray and white mat-




The ORACLE Study: Parents included in 
Focus cohort, a random sample and all 




Visit (6x) + addional tesng
Fig. 1  Flow of Generation R and the ORACLE Study. Parents 
were invited three times during pregnancy and returned to the 
research center with their children 5, 9 and 13  years after preg-
nancy. Additional detailed measurements of foetal and postnatal 
growth and development have been conducted in a subgroup of chil-
dren (n = 1232, known as the ‘Focus cohort’) and their parents at 
32 weeks gestational age and the postnatal ages of 1.5, 6, 14, 24, 36 
and 48  months. The ORACLE Study started as part of the 13-year 
research visit
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• map and quantify markers of cerebrovascular disease, 
i.e. white matter hyperintensities, brain infarcts (lacu-
nar and cortical) and microbleeds;
• map and quantify the cerebral blood flow.
We chose sequences and acquisition parameters that 
were comparable to the acquisition protocols of the Gener-
ation R Study and the Rotterdam Study while constraining 
the scanning time to 30 min. The finalized scan protocol 
is shown in Table 1.
Participants are excluded if they have any contraindica-
tions for the MRI, like metal implants or claustrophobia.
Scanner and equipment
As of 2013, the Generation R Study has a dedicated MRI 
scanner in the Erasmus MC-Sophia hospital [35], the same 
hospital that houses the Generation R research center. We 
are performing the ORACLE Study on this MRI scanner 
as well, in order to make the images more comparable to 
the images of the Generation R Study children. The scan-
ner is a 3 T GE Discovery MR750w MRI System (General 
Electric, Milwaukee, WI, USA) with the GE DV24 soft-
ware package. The software package has intentionally not 
been updated since 2014, to ensure that the images remain 
relatively unchanged over the years. Images are obtained 
using an eight-channel head coil.
Several steps are undertaken to ensure comfort of the 
participants and to reduce participant motion. To reduce 
noise levels the participants are given earplugs and addi-
tionally headphones if this fits into the head coil. To ensure 
immobility of the head we use bilateral soft cushioning. 
A stiff cushion is also placed under the legs of the par-
ticipants to reduce discomfort during scanning. Partici-
pants with back problems are offered additional pillows 
and other support. Finally, all participants are shown the 
same nature documentary during the scanning unless they 
prefer not to.
Image acquisition
The session starts with a three-plane localizer for posi-
tioning, and an ASSET scan to enable parallel imaging. 
 T1-weighted images to assess the structure of the brain are 
obtained using a 3D axial inversion recovery fast spoiled 
gradient recalled sequence (1 × 1 × 1 mm3). The sequence 
is further accelerated by a factor of 2 using autocalibrating 
reconstruction for Cartesian imaging (ARC). White mat-
ter microstructural integrity is assessed with an axial spin 
echo sequence with an echo planar imaging (EPI) readout 
(2 × 2 × 2  mm3). The gradient is set at b = 1000 m/s2 in 35 
directions with a posterior-anterior phase encoding direc-
tion. In addition, 3 sets of images with a gradient of b = 0 m/
s2 are collected. To be able to perform susceptibility distor-
tion correction we also collect 3 sets of b = 0 m/s2 images 
with an anterior–posterior phase encoding direction.
White matter lesions and infarcts are visualized using 
a 2D axial fluid-attenuated inversion recovery (FLAIR) 
sequence (0.8 × 1.1 × 2.5  mm3). To visualize microbleeds we 
use a  T2*-weighted sequence (0.8 × 1.1 × 1.0  mm3). Both of 
these are based on the sequence parameters of the Rotterdam 
Study to promote cross-study comparisons [36]. We further 
assess local blood perfusion with a pseudo-continuous arte-
rial spin labeling (pcASL) sequence with three postlabe-
ling delays (1000, 1570 and 2460 ms). The total cerebral 
blood flow is quantified using an ungated 3D phase contrast 
sequence (velocity encoding = 80 cm/s) and based on the 
blood flow through the carotids and the basilar arteries.
Examples of each sequence have been compiled into 
Fig. 3. Once the scanning session is completed, the images 
are send and stored in an XNAT storage instance [37].
Quality assessment
An initial assessment of general image quality is made by 
the radiographer during the scanning for the  T1-weighted 
sequence. The quality of the  T1-weighted scans is classified 
as poor, questionable, good or excellent. In most cases, poor 
Fig. 2  Schematic overview of the ORACLE Study research visit. MRI Magnetic resonance imaging, FLAIR Fluid-attenuated inversion recovery; 
pcASL Pseudo-continuous arterial spin labeling, CES-D Center for Epidemiological Studies – Depression scale
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quality scans seem to be due to excessive movement. If the 
scans are rated as poor or questionable, the radiographer 
instructs the participant to try to lay as still as possible, and 
that the  T1-weighted sequence will be repeated.
Image quality of all sequences is further assessed dur-
ing and after image processing with manual and automated 
methods.  T1-weighted segmentations are visually inspected 
by trained raters and each scan receives a fail/pass rating on 
a global level. This is done by rating a subset of slices in all 
three orientations (i.e. axial, coronal and sagittal) as well as 
the 3D reconstructions of the white and pial surfaces.
T1-weighted images are also processed through a vali-
dated and automated quality assessment pipeline [38]. 
Images with low ratings from this pipeline are reinspected 
by the raters, and excluded if justified. Furthermore, the 
quality rating from the automated pipeline will be used 
as a covariate in MRI-related projects, to see whether the 
analyses are confounded by subtle differences in image and 
processing quality.
Incidental findings
A by-product of population-based neuroimaging is the detec-
tion of incidental findings (IFs), i.e. abnormalities that are 
unrelated to the aims of the study but could bear clinical 
relevance. A meta-analysis study estimated the prevalence 
of such findings for brain MRI to be 2.7%, with neoplas-
tic findings in about 0.7% of individuals [39]. However, it 
remains unclear what the best course of action is for inci-
dental findings. For example, a follow-up study found that 
small meningiomas, the most common neoplastic finding, 
tend to remain stable and thus clinical intervention is not 
needed [40]. The UK Biobank also found that the majority 
of clinical referrals of incidental findings did not benefit the 
participants while being accompanied by side effects such 
as emotional distress [41]. Incidental findings are thus to be 
expected but should be approached conservatively, to mini-
mize burden on the participants.
Similar to the Generation R child neuroimaging waves 
we opted for a two-layered approach in incidental finding 
detection and management [35]. The first layer takes place 
during the scanning session itself. The radiographer scrolls 
through the  T1-weighted images once, to detect any gross 
abnormalities. If any are detected, a certified neuroradiolo-
gist is contacted (author: MWV). The second layer is post-
hoc inspection of the  T1-weighted images, the DWI images, 
the FLAIR images and the T2*-weighted images by trained 
personnel. A certified neuroradiologist subsequently checks 
all findings (author: MWV). When a finding is deemed clini-
cally relevant, it is discussed in a broader consensus meeting 
where the decision is made to refer the patient for further 
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Cognitive testing
All participants are tested individually by trained examin-
ers. The participants are told that they will take part in sev-
eral tests and are asked to try their best. If participants ask 
about the purpose of the test, the experimenter indicates that 
they cannot disclose this during the test battery. If partici-
pants indicate that they want to restart or that they feel like 
they are doing poorly, the experimenter encourages them 
to continue and finish the test. Spare glasses are available 
for visually impaired participants who did not bring their 
own. Audio is recorded for the entire cognitive test battery 
if the participant consented. If needed, a stopwatch is used 
to measure time.
15‑word learning test
The 15-word learning test is a neuropsychological test to 
assess the ability of verbal learning, retrieval and recognition 
of verbal memory [42]. The test consists of three subtasks 
[43]. The first subtask consists of three trials where the same 
15 unrelated words were used as stimuli. During each trial, 
the words are shown one by one on a computer screen, with 
a presentation time of 2 s per word, in the same order. After 
every trial, the participant is asked to name as many words 
as they can remember (immediate recall), and the trial is 
ended once the participant cannot recall any more words.
At least 20 min after the third trial, the participant is 
asked to name as many presented words as they can remem-
ber (delayed recall). Once the participant named all words 
that they can recall, they are presented with 15 previously 
shown words and 15 new words on the computer screen, 
one by one. The participants are asked to answer ‘Yes’ or 
‘No’ to whether the item belonged in the list of immediate 
recall (recognition). The number of correctly recalled words 
in each trial are scored as the main outcome measures [42].
Stroop task
The Stroop task is a neuropsychological test used to assess 
the ability to inhibit cognitive interference. Cognitive inter-
ference occurs when the processing of a specific stimulus 
feature impedes the simultaneous processing of a second 
stimulus attribute, known as the Stroop Effect [44, 45]. The 
Stroop task that is being used consists of three subtasks, and 
40 stimuli for each subtask are distributed evenly in a 4 by 
10 matrix [46]. The first subtask shows words of different 
colors (red, yellow, blue, or green) in black writing. The 
second subtask shows rectangles solidly colored in either 
red, yellow, blue or green. The third and last task shows 
the words of different colors (red, yellow, blue, or green) in 
Fig. 3  Example images from 
all sequences in the MRI 
protocol. a  T1-weighted, b 
diffusion-weighted, c FLAIR, d 
 T2*-weighted, e pcASL, f phase 
contrast
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dissimilar ink color [46]. Every task must be read aloud as 
quickly as possible without mistakes. There is no time limit 
to complete each subtask. The time in seconds needed for 
a subtask is given as dependent measures (reading subtask, 
color naming subtask, and color-word interference subtask 
respectively) [42].
Letter‑digit substitution test
The Letter-digit substitution test is a neuropsychological test 
to assess the ability of processing speed and executive func-
tion [42]. In the test, a key in which the numbers 1 to 9 are 
paired with a letter is given at the top of the worksheet [47]. 
Beneath the key, letters are given in a random order and the 
participant needs to pair the letters with the number accord-
ing to the key. The first ten items are used for practice to 
ensure that the participant understands the test instructions. 
Following the practice round, the participant needs to pair as 
many numbers with the letters within 60 s in the given order. 
The number of correct items is used as the outcome of the 
test, with the maximum being 125 points [42].
Verbal fluency test
The verbal fluency test is a neuropsychological test to assess 
the ability of the efficiency of searching in long-term mem-
ory [42]. An animal-based task is used, where participants 
are asked to generate as many animal names as possible 
within 60 s [48]. The number of correct animals is used 
as the outcome of the test [42]. Furthermore, the examin-
ers write out the answers in full for post-hoc construction 
of semantic networks across all participants [49, 50]. This 
can be done to determine the degree to which participants 
cluster within and switch between semantic categories of 
animals [50].
Purdue pegboard test
The Purdue pegboard test is a neuropsychological test to 
assess dexterity and fine motor skill [42]. The Purdue peg-
board is a rectangular board consisting of two columns of 
25 holes [51, 52]. Above these columns are reservoirs for 
metal pins. The participant needs to move the pins one at 
a time into the holes of the column on the same side of 
the board as the hand being used. They start at the top of 
the column and place as many pins as possible within 30 s. 
The task consists of three subtasks [51, 52]. The first task 
is with the dominant hand, followed by the non-dominant 
hand, and then using the left and right hand simultaneously. 
The numbers of moved pins for each subtask are used as the 
outcome measure [42].
Design organization test
The design organization test is a neuropsychological test to 
assess visuospatial ability [42, 53]. The participant is pre-
sented with nine designs consisting of squares. Six differ-
ent squares are used: 1 black square, 1 white square, and 
4 squares that are half-black and half-white divided along 
the diagonal in different orientations. Numbers from 1 to 6 
are assigned to each type of square, with a key at the top of 
the sheet. Participants have to convert the pattern designs 
to corresponding number designs. They have to fill in as 
many numbers as possible within 120 s. The first nine pat-
terns consist of 5 designs with 2 by 2 squares, followed by 
4 designs with 3 by 3 squares, and thus a maximum of 56 
points can be scored. The number of correct items completed 
is used as the outcome measure [42].
Gait assessment
The walking pattern, or gait, is a complex sequence of move-
ments integrating sensory information and motor commands 
[54–56]. Gait is considered an accurate reflection of general 
health and is influenced by many organ systems such as the 
central and peripheral nervous system, cardiovascular sys-
tem, and musculoskeletal system [57–59]. Gait is assessed 
with an electronic walkway using pressure sensors (GAI-
TRite; Sparta, NJ: 4.88-m active area; 120-Hz sampling rate) 
and is considered accurate to determine gait parameters. 
Participants perform a standardized gait protocol consisting 
of four different walking conditions: normal walk, turning, 
tandem walk, and dual task. In the normal walk, partici-
pants walk six times over the walkway at their own pace. In 
turning, participants walk at their usual pace, turn halfway 
and return to the starting position. In the tandem walk, par-
ticipants walk tandem (heel-to-toe) on the walkway. During 
the dual task, participants have to count down from a 100 
by seven while walking over the walkway. Raters inspect 
all recordings and identify individual footsteps. The GAI-
TRite software returns a broad range of parameters that are 
commonly summarized into seven independent gait domain: 
rhythm, phases, variability, pace, tandem, turning, and base 
of support. Until February 2018, the gait data were collected 
with the wireless GAITRite CIRFace system. We experi-
enced intermittent technical issues primarily related to loss 
of wireless signal. Since March 2018, the gait data has been 
collected with the wired GAITRite RE system. Both systems 
have the same settings and characteristics, and so the data 
from both systems will be used for analysis.
Blood pressure and anthropometry
Systolic and diastolic blood pressure are measured with 
the validated automatic sphygmomanometer Omron 907 
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(OMRON, Matsusaka Co., Ltd., Japan) [60]. All participants 
are seated in upright position with back support. Blood pres-
sure is measured two times over a 60-s interval, and the 
mean blood pressures are used for further analysis [61]. Fur-
thermore, body weight (kilograms) and body height (centim-
eters) are measured after participants take off their footwear.
Questionnaires
Migraine
Migraine is assessed with a validated screening question-
naire [62]. This questionnaire includes five questions ask-
ing whether the participant had (i) severe headaches in the 
past 12 months, (ii) what the headache severity was, (iii) 
whether the participant had suffered from headaches which 
were preceded by visual disturbances, (iv) whether the par-
ticipant had been diagnosed with migraine by a physician, 
and (v) whether the participant had ever used anti-migraine 
medication.
Depressive symptoms
Depressive symptoms are measured using the validated 
Dutch version of the Center for Epidemiologic Studies-
Depression Scale (CES-D) [63]. The CES-D comprises 
20 items, each with a possible score of 0–3, and the score 
ranges from 0–60.
Sleep propensity
Sleep propensity, one’s readiness to transition from an 
awake state to sleep, is measured with a Dutch version of 
The Epworth Sleepiness Scale [64]. The scale comprises 
8 items, each with a possible score of 0–3, and the score 
ranges from 0 to 24. Higher scores indicate higher levels of 
sleep propensity.
Handedness
Handedness is assessed using a modified version of the 
Edinburgh Handedness Inventory [65]. This inventory con-
tains questions on which hand someone prefers for a range 
of activities such as writing, holding a fork and striking a 
match. An option was added for both hands, to capture ambi-
dexterity. Furthermore, an item on eyedness (“which eye 
would you look with through a telescope”) and footedness 
(“which leg would you use to kick a ball”) were included as 
well. From these items, a laterality index ranging from -1 
(preference for left) to 1 (preference for right) is calculated.
Subjective memory complaints
Subjective memory complaints are assessed with four self-
reported question. The first question is “do you have more 
difficulty remembering things?” If participants answer 
“Yes”, three follow-up questions are asked: the year in which 
these problems seemed to start, whether the problems started 
suddenly (no/yes), and whether the problems have changed 
over time (no/yes).
Other self‑reported data
Additional information is obtained from participants through 
a semi-structured interview and a separate questionnaire. 
Participants are asked about their sleep during the last night 
(shorter, longer or the same as usual), and consumption of 
caffeine, nicotine, alcohol and drugs in the past 24 h. Fur-
thermore, participants are asked about their medical status 
(presence of diseases) as well as medication use. We specifi-
cally ask about neurological and psychiatric diseases and 
disorders. Women are asked about their menstrual cycle, 
i.e. whether they menstruate and when they last menstru-
ated. Finally, participants are asked whether their biologi-
cal mother or biological father have been diagnosed with 
dementia, Parkinson’s disease, schizophrenia or bipolar 
disease.
Current state of recruitment
Below we present the progress of the ORACLE Study from 
May 2017 up to September 2019. In total, 1579 individu-
als have been reached for an invitation to take part in the 
ORACLE Study, and 1307 (83%) have accepted that invita-
tion. Of the respondents, 169 were HDP women, and 135 
(80%) participated. Most participants were female (n = 842, 
64.4%). The mean age during the visit was 46.4 years for the 
women (standard deviation: 4.4, range: 33.0–60.9) and 49.0 
for the men (standard deviation: 5.0, range: 36.5–72.0). The 
mean follow-up time since the intake of the Generation R 
Study was 14.9 years (standard deviation: 0.8 years). Most 
participants (80.6%) reported to be of Dutch ancestry, 15.0% 
as non-Western and 4.4% as other Western. Finally, at study 
intake 58.8% of the participants had a university degree, 
37.8% only finished secondary (vocational) education, and 
3.4% only finished primary school or had no degree. An 
overview of the participation rates for each measurement 
is given in Table 2. Out of 1307 participants, 1280 (97.9%) 
completed at least one MRI sequence. The remaining partici-
pants did not participate in neuroimaging due to claustropho-
bia (n = 11), contraindications (n = 9), technical scan issues 
(n = 5) and participants having to leave early (n = 2). Of the 
scanned individuals, 1180 (92.2%) had complete data on all 
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sequences (99.8%  T1-weighted, 98.8% diffusion-weighted 
imaging, 99.1% FLAIR, 97.4%  T2*-weighted, 95.2% pcASL 
and 96.4% phase contrast). Early termination of a scan ses-
sion was most commonly due to anxious feelings. Further-
more, the pcASL and the phase contrast were sometimes 
skipped due to time constraints if the  T1-weighted sequence 
had to be rescanned for quality purposes. Finally, the diffu-
sion-weighted sequence was not performed in the first 11 
participants due to technical issues.
Participation rates for the other tests were generally close 
to 100% (Table 2). A number of measures have lower partici-
pation rates as they were introduced at a later time point dur-
ing data collection, i.e. the Purdue pegboard test, the design 
organization test, the blood pressure measurements and 
some of the questionnaires. In addition, the gait assessment 
experienced technical issues during the initial phase of the 
data collection, which resulted in a relatively low participa-
tion rate (78.0%). Other non-participation can be explained 
by participant refusal or inability to participate (e.g. muscle 
problems for the Purdue pegboard test), technical problems 
with the equipment (e.g. blood pressure measurements), or 
skipping of questions in questionnaires.
Discussion
Given the high response rates and the high quality of the 
collected data, the ORACLE Study will likely reach its goal 
of 2000 participants with a few more months of data collec-
tion. Once the data collection is completed the ORACLE 
Study will be open for collaborative projects. All requests 
for collaboration can be directed to study PI Professor M. 
Arfan Ikram (m.a.ikram@erasmusmc.nl).
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